Promoting Endogenous Danger Signals Accumulation by a Hierarchical Nanoinducer for Amplifying STING Pathway Activation-Mediated Tumor Immunotherapy
ACS Nano · 30.12.2025 · 19 (51) · 42853-42868
DOI: 10.1021/acsnano.5c15939 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 16.12.2025. Verfasst von Xiao-Kang Jin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, P. R. China. Hauptthemen laut MEDLINE: Membrane Proteins, Immunotherapy, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Given the clinical limitations of exogenous stimulators of interferon genes (STING) agonists in vivo, activating the cGAS-STING pathway through endogenous danger signals (EDSs) represents a promising alternative approach. Notably, effective activation of cGAS-STING pathway is critically dependent on intracellular EDSs levels. Herein, we report a pH-responsive hierarchical nanoinducer (FGMC) by encapsulating ferritin loaded with glucose oxidase/MK571 (ABCC1 transporter inhibitor) (FGM) into the MK571-Co2+ (MC) coordination shell. FGMC induces pyroptosis and accumulation of EDSs in tumor cells by disturbing intracellular homeostasis, thereby enhancing cGAS-STING pathway activation for immunotherapy. Within the tumor microenvironment, FGMC disrupts intracellular homeostasis of tumor cells through its enzymatic activity, leading to pyroptosis-mediated mitochondrial damage and mitoDNA release. Furthermore, the inhibition of glucose/NSUN2/TREX2 axis and ABCC1 transporter enhances intracellular accumulation of dsDNA and cyclic GMP-AMP, potently activating the cGAS-STING pathway. Late in pyroptosis, the dsDNA released from dead tumor cells activates the cGAS-STING pathway in dendritic cells. These effects evoke strong immunity to inhibit tumor growth and metastasis. This study highlights the potential of this hierarchical nanoinducer as an alternative to conventional STING.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, P. R. China.
ORCID-Profile: Jun-Long Liang, Xiao Yan, Chuan-Jun Liu, Xian-Zheng Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jin, X. K., Zhang, S. M., Xu, Z. H., Chen, H., Liang, J. L., Yan, X., Liu, C. J., & Zhang, X. Z. (2025). Promoting Endogenous Danger Signals Accumulation by a Hierarchical Nanoinducer for Amplifying STING Pathway Activation-Mediated Tumor Immunotherapy. ACS Nano, 19(51), 42853-42868. https://doi.org/10.1021/acsnano.5c15939
Vancouver
Jin XK, Zhang SM, Xu ZH, Chen H, Liang JL, Yan X, et al. Promoting Endogenous Danger Signals Accumulation by a Hierarchical Nanoinducer for Amplifying STING Pathway Activation-Mediated Tumor Immunotherapy. ACS Nano. 2025;19(51):42853-42868. doi:10.1021/acsnano.5c15939
BibTeX
@article{Jin2025,
author = {Jin, Xiao-Kang and Zhang, Shi-Man and Xu, Zi-Han and Chen, Hong and Liang, Jun-Long and Yan, Xiao and Liu, Chuan-Jun and Zhang, Xian-Zheng},
title = {Promoting Endogenous Danger Signals Accumulation by a Hierarchical Nanoinducer for Amplifying STING Pathway Activation-Mediated Tumor Immunotherapy},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {51},
pages = {42853--42868},
doi = {10.1021/acsnano.5c15939}
}
EUVIMED